rxstat › Shortages › Lurasidone

Lurasidone shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Lurasidone products are in shortage in Canada (1 of 19 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jun 19, 2026.
Products affected
1 / 19
In shortage since
Mar 1, 2026
Est. full return
Jun 19, 2026
Reports on file
34
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
TARO-LURASIDONE
120MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02504537 · since Mar 1, 2026, est. end Jun 19, 2026 · Disruption of the manufacture of the drug.
Anticipated
LATUDA
80MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02387778 · ended Jun 30, 2026 · Requirements related to complying with good manufacturing practices.
Anticipated
LATUDA
60MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02413361 · ended Jun 30, 2026 · Requirements related to complying with good manufacturing practices.
Anticipated
LATUDA
40MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02387751 · ended Jun 30, 2026 · Requirements related to complying with good manufacturing practices.
Anticipated
LATUDA
20MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02422050 · ended Jun 30, 2026 · Other (Please describe in comments)
Discontinued
LATUDA
40MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02387751
To be discontinued
LATUDA
20MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02422050
To be discontinued
LATUDA
20MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02422050
To be discontinued
LATUDA
20MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02422050
To be discontinued
LATUDA
80MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02387778
To be discontinued
LATUDA
60MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02413361
Resolved
TARO-LURASIDONE
60MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02504510 · ended Dec 19, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 34 reports. All reports are on file with Health Canada.

What's happening

Lurasidone is currently affected by an active shortage report filed with Health Canada by TARO PHARMACEUTICALS INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Lurasidone is classified under “ANTIPSYCHOTICS” (ATC N05AE).

Recent changes

Common questions

When will Lurasidone be back in stock in Canada?

The latest manufacturer estimate is Jun 19, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Lurasidone in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antipsychotics)

Widespread shortagePericiazine2 of 4 reported products affectedWidespread shortageTrifluoperazine5 of 5 reported products affectedPartial shortageAripiprazole3 of 29 reported products affected · est. return Jul 17, 2026Partial shortageFluphenazine1 of 2 reported products affected · est. return Jun 5, 2026Partial shortageHaloperidol6 of 16 reported products affected · est. return Jul 10, 2026Partial shortageLithium Carbonate4 of 11 reported products affected · est. return Jan 1, 2027

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.